TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25318784

Group type: EXPERIMENTAL
Intervention: Intensive gait training with rhythmic auditory stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intensive gait training (control group)
Number of subjects: 20
Study: 22770377

Group type: EXPERIMENTAL
Intervention: Salidroside (600 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 20581169

Group type: EXPERIMENTAL
Intervention: Imatinib 200 mg orally once daily (increased to 400 mg if well tolerated)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 59
Study: 18076223

Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Progressive static stretching
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dynamic stretching
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 7
Study: 15129736

Group type: EXPERIMENTAL
Intervention: Allopurinol pretreatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no allopurinol)
Number of subjects: 25
Study: 11419566

Group type: EXPERIMENTAL
Intervention: Metrifonate (30 to 60 mg by weight or a 50-mg fixed dose once daily)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Metrifonate
Number of subjects: 672

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 672
Study: 9521401

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Fragmin) 5,000 U once daily
Number of subjects: 566

Group type: COMPARATOR
Intervention: Sodium heparin 5,000 U twice daily
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Fragmin)
Number of subjects: 566

Group type: COMPARATOR
Intervention: Sodium heparin
Number of subjects: 566
Study: 7721127

Group type: EXPERIMENTAL
Intervention: Labor conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Profession, length of service, age
Number of subjects: 0
Study: 2685951

Group type: EXPERIMENTAL
Intervention: Uniphyllin (UP) taken as a single dose at bedtime
Number of subjects: 59

Group type: COMPARATOR
Intervention: Slophyllin (SP) taken twice daily
Number of subjects: 59
Study: 789170

Group type: EXPERIMENTAL
Intervention: N‐acetyl‐L‐glutamine aluminum complex (KW)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Basic aluminum sucrose sulfate (UL)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Inactive placebo of lactose (PL)
Number of subjects: 302
Study: 30935243

Group type: EXPERIMENTAL
Intervention: Workshop intervention on responsible reporting on suicide (RRS)
Number of subjects: 26
Study: 29392459

Group type: EXPERIMENTAL
Intervention: Individually tailored therapy plan and additional home visits (Intervention Group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard German neurological treatment (Control Group)
Number of subjects: 300
Study: 26863146

Group type: EXPERIMENTAL
Intervention: Exercise therapy (15 sessions over 5 weeks focusing on stretching and strengthening exercises)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Manual therapy (15 sessions including massage, mobilization, muscle energy and myofascial release)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 46
Study: 24851039

Group type: EXPERIMENTAL
Intervention: Spasmofen rectal suppository (100 mg ketoprofen and 10 mg hyoscine butylbromide)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ketorolac IV (30 mg/2 mL)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Spasmofen rectal suppository
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ketorolac IV
Number of subjects: 80
Study: 22935440

Group type: EXPERIMENTAL
Intervention: High-protein low-carbohydrate (HPLC)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: High-protein normal-carbohydrate (HPNC)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Normal-protein low-carbohydrate (NPLC)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Normal-protein normal-carbohydrate (NPNC)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Normal-carbohydrate (NC)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate (LC)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Normal-protein low-carbohydrate (NPLC) vs Normal-protein normal-carbohydrate (NPNC)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: High-protein diets vs Normal-protein diets
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: High-protein diets vs Low-carbohydrate diets
Number of subjects: 132
Study: 21154308

Group type: EXPERIMENTAL
Intervention: Tc-99m-MIBI
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tc-99m-antimony sulphide colloid
Number of subjects: 50
Study: 17669866

Group type: EXPERIMENTAL
Intervention: Cadence Contrast Pulse Sequencing ultrasound technique with Sono Vue
Number of subjects: 30

Group type: COMPARATOR
Intervention: Triphasic helical CT-scan
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both ultrasound and CT
Number of subjects: 30
Study: 16256897

Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention plus standard home-based palliative care (n = 54)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard home-based palliative care (n = 52)
Number of subjects: 106
Study: 12166881

Group type: EXPERIMENTAL
Intervention: Pressure-threshold inspiratory muscle training
Number of subjects: 16
Study: 10890237

Group type: EXPERIMENTAL
Intervention: Total amount of therapeutic interventions measured by the TISS‐28 score
Number of subjects: 0
Study: 8819179

Group type: EXPERIMENTAL
Intervention: BAY u 3405
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: S‐1452
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 2023538

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (PD), 120 mg administered orally
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo, two tablets administered orally
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline, 1 mL injected as an IV bolus
Number of subjects: 6
Study: 6266897

Group type: EXPERIMENTAL
Intervention: pivmecillinam/pivampicillin (pivmecillinam 200 mg plus pivampicillin 250 mg) three times daily (14 patients)
Number of subjects: 26

Group type: COMPARATOR
Intervention: pivmecillinam alone (400 mg three times daily) (12 patients)
Number of subjects: 26
Study: 31253621

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation (NACRT)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NACT) alone
Number of subjects: 314
Study: 27830281

Group type: EXPERIMENTAL
Intervention: Information brochure and website
Number of subjects: 332
Study: 25851766

Group type: EXPERIMENTAL
Intervention: Non-general anesthesia (non-GA)
Number of subjects: 348

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 348
Study: 25116461

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 139
Study: 22819061

Group type: EXPERIMENTAL
Intervention: Rehabilitation group (standardized, three‐stage rehabilitation program)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Control group (standard hospital ward, internal medical intervention)
Number of subjects: 364
Study: 21046699

Group type: EXPERIMENTAL
Intervention: Alcohol-based hand sanitizer
Number of subjects: 476

Group type: COMPARATOR
Intervention: Control group (no sanitizer)
Number of subjects: 476
Study: 17704088

Group type: EXPERIMENTAL
Intervention: Simulation (SIM)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Questionnaires (QUES)
Number of subjects: 84
Study: 16302598

Group type: EXPERIMENTAL
Intervention: Enameloplasty Sealant Technique (EST) using Tetric Flow resin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional Sealant Technique (CST) using Tetric Flow resin
Number of subjects: 40
Study: 12000235

Group type: EXPERIMENTAL
Intervention: Active group intervention designed to enhance risk perception and increase knowledge about HIV testing
Number of subjects: 398

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 398
Study: 9706932

Group type: EXPERIMENTAL
Intervention: Oral acetaminophen (1 g every 4 h)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 10155674

Group type: EXPERIMENTAL
Intervention: Late rescue surfactant therapy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Single-dose treatment of severely ill neonates
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Multiple-dose treatments
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Early treatment surfactant therapy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Prophylaxis surfactant therapy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Introduction of porcine-derived lung surfactant (PLS) therapy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: PLS therapy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Costs for PLS therapy
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Additional costs of PLS therapy per additional survivor
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Savings in costs per survivor
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Savings in costs per nonsurvivor
Number of subjects: 1000
Study: 2350628

Group type: EXPERIMENTAL
Intervention: High dose chemotherapy and total lymphoid irradiation with 750 cGy for severe aplastic anemia patients.
Number of subjects: 80

Group type: COMPARATOR
Intervention: High dose chemotherapy and single dose total body irradiation with 750-850 cGy for leukemia patients.
Number of subjects: 80

Group type: COMPARATOR
Intervention: High dose chemotherapy and fractionated total body irradiation with 1320 cGy for leukemia patients.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Methotrexate alone as prophylaxis for graft-versus-host disease in aplastic anemia patients.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Methotrexate, antithymocyte globulin and prednisone regimen as prophylaxis for graft-versus-host disease in aplastic anemia patients.
Number of subjects: 80
Study: 7448109

Group type: COMPARATOR
Intervention: Exercise (work load: 450 kpm/min for females, 600 kpm/min for males on a bicycle ergometer for 3 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rest (control condition)
Number of subjects: 0
Study: 30259172

Group type: EXPERIMENTAL
Intervention: Tolvaptan (TLV)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Furosemide (FUR)
Number of subjects: 81
Study: 28750964

Group type: EXPERIMENTAL
Intervention: Ischemic Compression (IC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lumbopelvic Manipulation (LPM)
Number of subjects: 40
Study: 24934652

Group type: EXPERIMENTAL
Intervention: Baseline partner victimization
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Baseline non-partner victimization
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Victimization at follow-up
Number of subjects: 603
Study: 23350660

Group type: EXPERIMENTAL
Intervention: Video group (watched a 13-min cartoon animation)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Nonvideo group (did not watch the animation)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups (video and nonvideo)
Number of subjects: 31
Study: 17261465

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg)
Number of subjects: 39
Study: 15037412

Group type: EXPERIMENTAL
Intervention: 4 mg of rosiglitazone daily for 3 months
Number of subjects: 24
Study: 10907386

Group type: EXPERIMENTAL
Intervention: Cloth towels accessed by a rotary dispenser
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Paper towels from a stack on the hand-washing sink
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Warm forced air from a mechanical hand-activated dryer
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Spontaneous room air evaporation
Number of subjects: 100
Study: 9116212

Group type: EXPERIMENTAL
Intervention: Event-related potentials (ERPs) recorded during memory source monitoring tasks
Number of subjects: 0
Study: 1640395

Group type: EXPERIMENTAL
Intervention: High psychopathology patients
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Low psychopathology patients
Number of subjects: 1020
Study: 3551675

Group type: EXPERIMENTAL
Intervention: Epidural pethidine 25 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Epidural saline
Number of subjects: 200
Study: 31367733

Group type: EXPERIMENTAL
Intervention: Combined program of textured lunch gatherings with oral and physical exercises (12-week program, twice a week)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group performing physical exercise regimen only
Number of subjects: 86
Study: 28422460

Group type: EXPERIMENTAL
Intervention: Philips Sonicare FlexCare Platinum with Premium plaque control brush head (PC)
Number of subjects: 143

Group type: COMPARATOR
Intervention: ADA Reference manual toothbrush (MTB)
Number of subjects: 143
Study: 25544263

Group type: EXPERIMENTAL
Intervention: sugammadex 2 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: neostigmine (70 μg/kg) and atropine (0.4 mg per mg neostigmine)
Number of subjects: 100
Study: 24085261

Group type: EXPERIMENTAL
Intervention: CYP3A4 inhibitor (ketoconazole 400 mg daily for 10 days)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: CYP3A4 inducer (rifampicin 600 mg daily for 14 days)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Midostaurin (single dose 100 mg and multiple doses 50 mg twice daily)
Number of subjects: 3
Study: 21392603

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard therapy (intravenous immunoglobulin and aspirin)
Number of subjects: 110
Study: 19207622

Group type: EXPERIMENTAL
Intervention: Creative expression workshops (experimental group)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 105
Study: 16934470

Group type: EXPERIMENTAL
Intervention: Dual Carbon Fiber Spring AFO (CFO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: common posterior leaf‐spring (PLS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: barefoot walking
Number of subjects: 15

Group type: COMPARATOR
Intervention: shoes without AFO
Number of subjects: 15
Study: 15326145

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin-containing ocular gelling minitablets
Number of subjects: 6

Group type: COMPARATOR
Intervention: Eye drop
Number of subjects: 6
Study: 11241570

Group type: EXPERIMENTAL
Intervention: Kaplan-Meier method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cause-specific cumulative incidence rates (conventional method)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified Cox method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cause-specific cumulative incidence rates (Kaplan-Meier estimates)
Number of subjects: 0
Study: 9068334

Group type: EXPERIMENTAL
Intervention: Intra-articular tenoxicam 20 mg
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Intra-articular bupivacaine 0.25%
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 63
Study: 8376613

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 3740174

Group type: EXPERIMENTAL
Intervention: 0.25% fluorometholone
Number of subjects: 14

Group type: COMPARATOR
Intervention: 0.1% dexamethasone sodium phosphate
Number of subjects: 14
Study: 29335773

Group type: EXPERIMENTAL
Intervention: Ergomotor (EM) intervention
Number of subjects: 101

Group type: COMPARATOR
Intervention: Conventional physiotherapy (CO)
Number of subjects: 101
Study: 27784021

Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment (monthly or individualized dosing)
Number of subjects: 1631

Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment (delayed responders)
Number of subjects: 1631

Group type: EXPERIMENTAL
Intervention: Baseline visual acuity (VA)
Number of subjects: 1631
Study: 24888911

Group type: EXPERIMENTAL
Intervention: Combination of Foley catheter and low-dose vaginal misoprostol
Number of subjects: 126

Group type: COMPARATOR
Intervention: Low-dose vaginal misoprostol alone
Number of subjects: 126
Study: 22317753

Group type: EXPERIMENTAL
Intervention: Grief and Trauma Intervention with coping skills and trauma narrative processing (GTI-CN)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Grief and Trauma Intervention with coping skills only (GTI-C)
Number of subjects: 70
Study: 19782352

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ghrelin (1 microg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 18654870

Group type: EXPERIMENTAL
Intervention: Undiluted smallpox vaccine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Threefold diluted smallpox vaccine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sixfold diluted smallpox vaccine
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Adverse events reported
Number of subjects: 104
Study: 15971472

Group type: EXPERIMENTAL
Intervention: Fluticasone/salmeterol combination via Diskus (n = 39) for 1 year
Number of subjects: 78

Group type: COMPARATOR
Intervention: Usual care control group (n = 39)
Number of subjects: 78
Study: 12647930

Group type: EXPERIMENTAL
Intervention: Kangaroo Care (KC) over 24.31 days (SD 7.24) for a total of 29.76 hours (SD 12.86)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Kangaroo Care (KC)
Number of subjects: 70
Study: 10556107

Group type: EXPERIMENTAL
Intervention: alpha(1)‐antitrypsin infusion (250 mg/kg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: albumin infusion (625 mg/kg)
Number of subjects: 56
Study: 8818828

Group type: EXPERIMENTAL
Intervention: Oral co‐trimoxazole 960 mg od or three times a week for primary and secondary prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Co‐trimoxazole 120 mg/kg/day in divided doses for 21 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV pentamidine for severe disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral dapsone with trimethoprim, oral clindamycin with primaquine, or IV pentamidine for mild or moderately severe disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant glucocorticoids
Number of subjects: 0
Study: 1823530

Group type: EXPERIMENTAL
Intervention: Diuretics alone
Number of subjects: 759

Group type: COMPARATOR
Intervention: Untreated hypertension
Number of subjects: 759
Study: 6827129

Group type: EXPERIMENTAL
Intervention: Sunscreen protection during UVB irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: UVB irradiation without sunscreen
Number of subjects: 0
Study: 30638484

Group type: EXPERIMENTAL
Intervention: Far-infrared radiation (FIR)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 29049303

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra virgin olive oil and pistachios (IG)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard diet with limited fat intake (CG)
Number of subjects: 1000
Study: 27035157

Group type: EXPERIMENTAL
Intervention: Auditory focused cognitive remediation (Brain Fitness)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (nonspecific video games)
Number of subjects: 120
Study: 24487087

Group type: EXPERIMENTAL
Intervention: Interatrial shunt (diameter up to 12 mm)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Interatrial shunt (diameter of 8-9 mm)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Interatrial shunt
Number of subjects: 2
Study: 23484334

Group type: EXPERIMENTAL
Intervention: Single-dose Rifampicin, Ofloxacin and Minocycline (ROM)
Number of subjects: 1526

Group type: COMPARATOR
Intervention: WHO-PB-MDT
Number of subjects: 1526
Study: 19540162

Group type: EXPERIMENTAL
Intervention: LBC combined with HPV testing (revealed)
Number of subjects: 24510

Group type: COMPARATOR
Intervention: LBC combined with HPV testing (concealed)
Number of subjects: 24510
Study: 17638804

Group type: EXPERIMENTAL
Intervention: Single-dose cefmetazole just before skin incision
Number of subjects: 377

Group type: COMPARATOR
Intervention: Three doses of cefmetazole (1 dose just before skin incision and 2 additional doses every 8 hours)
Number of subjects: 377
Study: 15047650

Group type: EXPERIMENTAL
Intervention: Vitamin therapy (vitamins C and E)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 299
Study: 12186248

Group type: EXPERIMENTAL
Intervention: 12-week skill-oriented program with increasing self-testing activities
Number of subjects: 45

Group type: COMPARATOR
Intervention: Regular 12-week physical education school program
Number of subjects: 45
Study: 9796323

Group type: EXPERIMENTAL
Intervention: Primary PTCA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous thrombolytic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heparin-coated Palmaz-Schatz stent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coronary stenting
Number of subjects: 0
Study: 8000624

Group type: COMPARATOR
Intervention: Intravenous streptokinase
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Primary coronary angioplasty
Number of subjects: 301
Study: 3189203

Group type: EXPERIMENTAL
Intervention: Girth measurements (mean abdomen, buttocks, right thigh)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Cross-validation of girth measurement equations
Number of subjects: 156
Study: 29618280

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT) for 16 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Stretching control for 16 weeks
Number of subjects: 10
Study: 31079533

Group type: EXPERIMENTAL
Intervention: Serum phosphate (measured as per SD increment)
Number of subjects: 10612

Group type: EXPERIMENTAL
Intervention: Serum phosphate (assessed as quartiles)
Number of subjects: 10612
Study: 28497384

Group type: EXPERIMENTAL
Intervention: Single-leg cycling (continuous at 50% PPO)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single-leg cycling (interval at 65% PPO and 20% PPO)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Double-leg cycling (interval and continuous)
Number of subjects: 12
Study: 25451627

Group type: EXPERIMENTAL
Intervention: Jyoti meditation (8-week program with weekly 90-minute classes)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Home-based exercise program (control group)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Jyoti meditation
Number of subjects: 89